Affiliation:
1. National Medical Research Center for Therapy and Preventive Medicine
Abstract
Familial dysbetalipoproteinemia (FD) is a genetic, highly atherogenic disorder. The penetrance of FD depends on the patient’s lifestyle and concomitant diseases. Despite the fact that FD was described almost half a century ago, it is still insufficiently studied and is extremely rarely diagnosed. In actual clinical practice, physicians do not have clear understanding of clinical course and genetic basis of FD. The aim was to present the most complete, but at the same time a critical review with a modern view on FD. We analyzed Russian and foreign publications from following electronic databases: PubMed, eLIBRARY, Google Scholar. As a result, the phenotypic features and genetic variability of the disease were considered and the main issues of diagnosis and treatment of patients with FD were discussed. The data presented will help the clinician to timely suspect the FD, conduct a full range of investigations and prescribe evidence-based lipid-lowering therapy.
Subject
Cardiology and Cardiovascular Medicine
Reference46 articles.
1. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.
2. Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Journal of atherosclerosis and dyslipisemias. 2020;11(1):38. (In Russ.) doi:10.34687/2219-8202.JAD.2020.01.0002.
3. Blum CB. Type III Hyperlipoproteinemia: still worth considering? Prog Cardiovasc Dis. 2016;59(2):119-24. doi:10.1016/j.pcad.2016.07.007.
4. Chepetova TV, Meshkov AN. Hypertriglyceridemia: etiology, pathogenesis, diagnostics. Cardiovascular Therapy and Prevention. 2006;5(5):94-100. (In Russ.)
5. Koopal C, Marais AD, Westerink J, et al. Autosomal dominant familial dysbetalipoproteinemia: a pathophysiological framework and practical approach to diagnosis and therapy. J Clin Lipidol. 2017;11(1):12-23. doi:10.1016/j.jacl.2016.10.001.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献